Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios A Dimopoulos

Showing results (91-100 of 740) with videos related to

Pageof 74
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustardsVassilis L Souliotis, Meletios A Dimopoulos, Petros P Sfikakis
Cancer Treatment Reviews|September 8, 2009
Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphomaEirini Katodritou, Meletios A Dimopoulos, Konstantinos Zervas, et al.
Expert Opinion on Drug Safety|January 7, 2017
Efficacy and safety of elotuzumab for the treatment of multiple myelomaMaria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, et al.
Expert Opinion on Investigational Drugs|January 4, 2017
Current treatment options and investigational drugs for Waldenstrom's MacroglobulinemiaMaria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, et al.
Cancer Treatment Reviews|August 23, 2015
Clinical characteristics of patients with relapsed multiple myelomaMeletios A Dimopoulos, Evangelos Terpos, Ruben Niesvizky, et al.
Acta Haematologica|June 15, 2020
Solid Organ Transplantation in AmyloidosisFoteini Theodorakakou, Despina Fotiou, Meletios A Dimopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 14, 2021
Real-World Treatment of Patients With Relapsed/Refractory MyelomaIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos, et al.
Clinical & Developmental Immunology|February 15, 2011
Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilizationNikos G Gavalas, Alexandra Karadimou, Meletios A Dimopoulos, et al.
European Journal of Haematology|October 15, 2010
Emerging therapies for the treatment of relapsed or refractory multiple myelomaMeletios A Dimopoulos, Jesus F San-Miguel, Kenneth C Anderson
International Journal of Molecular Sciences|December 23, 2022
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple MyelomaMaria Gkotzamanidou, Evangelos Terpos, Meletios A Dimopoulos, et al.
Pageof 74

Showing results (91-100 of 740) with videos related to

Sort By:
Pageof 74
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustardsVassilis L Souliotis, Meletios A Dimopoulos, Petros P Sfikakis
Cancer Treatment Reviews|September 8, 2009
Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphomaEirini Katodritou, Meletios A Dimopoulos, Konstantinos Zervas, et al.
Expert Opinion on Drug Safety|January 7, 2017
Efficacy and safety of elotuzumab for the treatment of multiple myelomaMaria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, et al.
Expert Opinion on Investigational Drugs|January 4, 2017
Current treatment options and investigational drugs for Waldenstrom's MacroglobulinemiaMaria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, et al.
Cancer Treatment Reviews|August 23, 2015
Clinical characteristics of patients with relapsed multiple myelomaMeletios A Dimopoulos, Evangelos Terpos, Ruben Niesvizky, et al.
Acta Haematologica|June 15, 2020
Solid Organ Transplantation in AmyloidosisFoteini Theodorakakou, Despina Fotiou, Meletios A Dimopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 14, 2021
Real-World Treatment of Patients With Relapsed/Refractory MyelomaIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos, et al.
Clinical & Developmental Immunology|February 15, 2011
Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilizationNikos G Gavalas, Alexandra Karadimou, Meletios A Dimopoulos, et al.
European Journal of Haematology|October 15, 2010
Emerging therapies for the treatment of relapsed or refractory multiple myelomaMeletios A Dimopoulos, Jesus F San-Miguel, Kenneth C Anderson
International Journal of Molecular Sciences|December 23, 2022
The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple MyelomaMaria Gkotzamanidou, Evangelos Terpos, Meletios A Dimopoulos, et al.
Pageof 74